Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 404,600 | 4,060,500 | 3,702,900 | 2,999,000 | 1,392,600 |
| Depreciation Amortization | 146,900 | 457,200 | 366,800 | 232,800 | 119,900 |
| Income taxes - deferred | -15,000 | 149,000 | 211,900 | 180,200 | 36,900 |
| Accounts receivable | 37,200 | 2,800 | -135,700 | -268,800 | -238,400 |
| Other Working Capital | -331,200 | -187,200 | -52,100 | -234,800 | -327,900 |
| Other Operating Activity | 526,500 | -252,500 | 503,100 | 507,400 | 484,200 |
| Operating Cash Flow | $769,000 | $4,229,800 | $4,596,900 | $3,415,800 | $1,467,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -92,600 | -424,800 | -338,800 | -254,700 | -149,700 |
| Net Acquisitions | 28,100 | -1,006,500 | -565,500 | -141,800 | N/A |
| Purchase Of Investment | -913,300 | -6,397,700 | -4,649,100 | -3,753,900 | -1,684,700 |
| Sale Of Investment | 910,400 | 7,374,300 | 5,241,200 | 3,880,400 | 2,389,800 |
| Purchase Sale Intangibles | N/A | -127,000 | -112,000 | -112,000 | -112,000 |
| Other Investing Activity | 2,700 | -153,900 | -130,000 | -119,800 | -112,500 |
| Investing Cash Flow | $-64,700 | $-608,600 | $-442,200 | $-389,800 | $442,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,967,400 | 1,467,300 | 1,467,300 | N/A |
| Debt Repayment | -169,300 | -1,500,000 | N/A | N/A | N/A |
| Common Stock Issued | -27,100 | -4,600 | N/A | -19,200 | N/A |
| Common Stock Repurchased | -600,000 | -6,679,100 | -6,279,100 | -5,029,100 | -2,249,800 |
| Other Financing Activity | 11,400 | -56,400 | -59,800 | 22,300 | 4,500 |
| Financing Cash Flow | $-785,000 | $-5,272,700 | $-4,871,600 | $-3,558,700 | $-2,245,300 |
| Exchange Rate Effect | -33,000 | 69,000 | 28,000 | 3,900 | 12,700 |
| Beginning Cash Position | 1,331,200 | 2,913,700 | 2,913,700 | 2,913,700 | 2,913,700 |
| End Cash Position | 1,217,500 | 1,331,200 | 2,224,800 | 2,384,900 | 2,591,300 |
| Net Cash Flow | $-113,700 | $-1,582,500 | $-688,900 | $-528,800 | $-322,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 769,000 | 4,229,800 | 4,596,900 | 3,415,800 | 1,467,300 |
| Capital Expenditure | -92,600 | -424,800 | -338,800 | -254,700 | -149,700 |
| Free Cash Flow | 676,400 | 3,805,000 | 4,258,100 | 3,161,100 | 1,317,600 |